Department of Pharmacognosy, College of Pharmacy, Naval Medical University, Shanghai, 200433, China.
Department of Health Care, Changhai Hospital,Naval Medical University, Shanghai, 200433, China.
J Ethnopharmacol. 2021 Oct 5;278:114279. doi: 10.1016/j.jep.2021.114279. Epub 2021 Jun 1.
Nicotiflorin is a flavonoid glycoside derived from the traditional Chinese medicine FlosCarthami, dried petals of Carthamus tinctorius L., and has been confirmed to be a promising novel drug candidate for ischemic stroke. Yet, the exact role of nicotiflorin in cerebral I/R injury is uncharacterized and the possible mechanisms have not been clearly expounded.
The present study was designed to determine the effect of nicotiflorin on cerebral ischemia/reperfusion (I/R) injury and its relationship with autophagy.
Middle cerebral artery occlusion (MCAO) in rats and oxygen-glucose deprivation and reintroduction (OGD/R) in SH-SY5Y cells were established in in vivo and in vitro models, respectively. The severity of MCAO was assessed by brain infarct size, neurological scores and survival rate. The severity of OGD/R was evaluated by cell viability, lactate dehydrogenase (LDH) release and cell apoptosis. The level of autophagy was evaluated both in vivo and in vitro. Autophagosomes were observed using transmission electron microscopy and autophagic flux was measured using mRFP-GFP-tandem fluorescent LC3 adenovirus. Autophagy-related proteins (LC3-II/I, SQSTM1, beclin-1, Phospho-mTOR/mTOR) were measured by immunoblot. Autophagy-related mRNA levels (Becn1, Atg7) were detected by Real-Time PCR. Inhibition of autophagy was implemented by 3-Methyladenine (3-MA) or chloroquine in vitro.
In vivo, nicotiflorin treatment alleviated brain damage and neurological deficit while it dramatically increased 72 h survival rate in rats. In vitro, nicotiflorin treatment also ameliorated the severity of OGD/R. Moreover, nicotiflorin treatment increased ischemic penumbra autophagy (autophagosomes, BECN1, LC3-II/I ratio, SQSTM1, Phospho-mTOR/mTOR, Atg7). In vitro, nicotiflorin likewise enhanced autophagy and promoted autophagy flux. Furthermore, the blockade of autophagy by 3-MA or chloroquine disabled the efficacic of nicotiflorin in preventing cell damage upon OGD/R insult.
These findings suggest that autophagy plays a significant role in the protective effect of nicotiflorin against ischemic stroke.
野黄芩苷是一种黄酮苷类化合物,来源于传统中药红花,即菊科植物红花的干燥花瓣,已被证实是缺血性中风有前途的新型候选药物。然而,野黄芩苷在脑缺血再灌注(I/R)损伤中的确切作用尚不清楚,其可能的机制也尚未阐明。
本研究旨在确定野黄芩苷对脑缺血再灌注(I/R)损伤的影响及其与自噬的关系。
在体内和体外模型中分别建立了大鼠大脑中动脉闭塞(MCAO)和氧葡萄糖剥夺和再引入(OGD/R)。通过脑梗死面积、神经评分和存活率评估 MCAO 的严重程度。通过细胞活力、乳酸脱氢酶(LDH)释放和细胞凋亡评估 OGD/R 的严重程度。在体内和体外评估自噬水平。通过透射电子显微镜观察自噬体,通过 mRFP-GFP-串联荧光 LC3 腺病毒测量自噬流。通过免疫印迹测量自噬相关蛋白(LC3-II/I、SQSTM1、beclin-1、磷酸化 mTOR/mTOR)。通过实时 PCR 检测自噬相关 mRNA 水平(Becn1、Atg7)。在体外通过 3-甲基腺嘌呤(3-MA)或氯喹抑制自噬。
体内,野黄芩苷治疗减轻了脑损伤和神经功能缺损,同时显著提高了大鼠 72 小时存活率。在体外,野黄芩苷治疗也改善了 OGD/R 的严重程度。此外,野黄芩苷治疗增加了缺血半影区自噬(自噬体、BECN1、LC3-II/I 比值、SQSTM1、磷酸化 mTOR/mTOR、Atg7)。在体外,野黄芩苷同样增强了自噬并促进了自噬流。此外,3-MA 或氯喹阻断自噬可使野黄芩苷在 OGD/R 损伤后防止细胞损伤的效果失效。
这些发现表明自噬在野黄芩苷对缺血性中风的保护作用中起重要作用。